October 1-3, 2021
$995.00
Provider
$695.00
Support Staff
Live Stream + In Person | Lost Pines Resort
Price includes course fees only
Description | Objectives | Agenda | Speakers | Travel
Course Description
Two years ago Jason Fung, MD spoke to our group. It changed lives for hundreds of providers and thousands of patients. His concise explanation for the use of intermittent fasting and controlling insulin resistance for his diabetic and obese patients was a paradigm shift in how patients are treated. Combined with hormone therapy, the results from your patients has been in some cases miraculous. His books The Obesity Code and The Diabetes Code are international best sellers.
He was so impressed with our group of providers who are so vested in doing ‘right’ for their patients that he has agreed to come back and speak to us about his new book The Cancer Code.
As quoted from the introduction to his new book, Dr. Fung sheds light on the strange and fascinating story of cancer, from how it develops to why a cure has proved elusive. Cancer is not a foreign invader; in fact, it is an uprising of our own healthy cells. He traces the arc of cancer research – from the myopic focus on genetics, the ‘seed’ of cancer, to our understanding of the ‘soil,’ or the conditions under which cancer flourishes. He explains the disease process itself from the cancerous transformation of a normal cell to its progression and metastasis and factors like nutrition, obesity, and type 2 diabetes can influence risk.
We are sick. Around the world, we struggle with diseases that were once considered rare. Cancer, heart disease, Alzheimer’s disease, and diabetes affect millions each year; many people are also struggling with hypertension, weight gain, fatty liver, dementia, low testosterone, menstrual irregularities and infertility, and more. We treat the symptoms, not realizing that all of these diseases and disorders have something in common.
Each of them is caused or made worse by a condition known as insulin resistance. And you might have it. Odds are you do—over half of all adults in the United States are insulin resistant, with most other countries either worse or not far behind
We will spend a significant amount of time on our body’s inflammatory processes and understanding how it effects our health. An integrated oncologist will help us look at options both traditional and alternative and how each plays a role in managing cancer. This includes what and when we eat and how this ties in with insulin resistance.
From here the topic transitions back to hormones with our esteemed mentor Dr. Rouzier as he drives home messaging on hormones and their significant impact on cancer, insulin resistance, obesity and diabetes with all new research articles. A new edition this year will be several lectures by Madeline Deutsch, MD related to transgender and non-binary clinical care. It is truly an underserved community that needs our attention and expertise in patient management of hormones
Finally Deb York will walk us through do’s and don’ts for primary care providers on suicide in clinical practice. It’s a sobering topic but she is vested in helping providers understand the use of additional tools of psychopharmacogenetics to assist in selecting the right drug, for the right patient and at the right dose.
Please join us for this extraordinary hybrid event offered in-person at the Lost Pines Hyatt Resort in Austin, TX OR live streamed to your home. This symposium tells a story of chronic illness and illustrates over 2.5 days what it is and what we can do about it. We as a community can have a significant impact in changing this chronic disease paradigm. The more of you that attend the greater the change will be.
Course Objectives
- Define and identify new guidelines to predict the risk/occurrence of CVD by measuring MRI generated LDL particle number compared to small-LDL particles.
- Describe Apolipoprotein B particles and CVD as Apolipoprotein B unifies, amplifies, and simplifies the information from Lipid markers on the atherogenic risk attributed to Apo-B lipoproteins.
- Recall how plaque development is predicted by apo-B levels in the blood and how transport, exposure to vessel walls, length of exposure, and removal by the liver plays a role in plaque expansion.
- Identify how HDL and apo-A1 plays a role in plaque reversal by controlling monocyte activation, adhesiveness, inflammation and reducing macrophage foam cells.
- Describe how Estradiol reverses insulin resistance and decreases the coronary calcification induced by statins and thereby leading to reversal of plaque and decrease in CVD events.
- Discuss and analyze how insulin and glucose levels change with insulin resistance.
- Examine how elevated insulin alters insulin sensitivity.
- Demonstrate how fat cells contribute to insulin resistance.
- Discuss the history of how cancer treatments developed according to the prevailing paradigms.
- Analyze the shortcomings of the genetic paradigm of cancer, the somatic mutation theory
- Discuss newer insights into the evolutionary paradigm of cancer
- Evaluate the role of vitamin deficiency in cancer
- Determine the role of obesity and metabolic disease in cancer
- Analyze the under fill and overflow hypotheses of insulin resistance
- Illustrate how type 2 diabetes may be reversed
- Review how hyperinsulinemia plays a key role in metabolic disease
- Compare the issues with endocrine therapy for breast cancer and the long-term risks of increased mortality from DM, osteoporosis and CVD.
- Explain how diabetes and cancer increase the risk of dying prematurely and how estrogen blockers, aromatase inhibitors, statins, BP meds, SSRI’s, LH-RH inhibitors and 5-a-reductase inhibitors contribute to increase IR and Type 2 Diabetes.
- Interpret the research studies that shows decreased testosterone levels with statin use and the increased risk for developing prostate cancer.
- Differentiate how LH-RH agonists are used for the treatment of prostate cancer in spite of increased mortality and how estrogen therapy is a proven treatment for over 70 years with minimal side effects.
Agenda
Registration
7:00 – 8:00 AM (Central Time)
7:30 AM Live Stream Opens
7:50 – 8:00 AM
Introduction – Dana Burnett, M.Ed.
8:00 – 9:00 AM
CVD Update: It’s Not What We’ve Been Taught; It’s so Much More
- Beta-cell dysfunction leading to insulin resistance
- LDL-C is not predictive of CVD
- Inflammation is the cause of IR, CVD, cancer and many other illnesses
- What’s the Treatment?
Faculty Chairman – Neal Rouzier, MD
9:00 – 10:00 AM
What’s the Secret to Reducing Apo-B Levels?
- How can we avoid the statin-induced mitochondrial toxicity which diminishes the benefit of statins?
- The Benefits of statins outweigh the risk? However this is only for CVD
- What can be added to statins to eliminate this risk?
- Apoliproprotein B unifies, amplifies, and simplifies conventional lipid markers.
- “Hypertriglyceridemia (and low HDL) is more common in patients with cardiovascular disease than hypercholesterolemia (JAMA 2019).”
Faculty Chairman – Neal Rouzier, MD
10:00 – 10:30 AM – BREAK
10:30 – 11:30 AM
The inflammation-centric model defines atherosclerosis. “The lowest levels of LDL-C cholesterol are strongly and independently associated with increased risk of cancer and all-cause mortality (Journal of Clinical Medicine 2019).” “This is a paradoxical contradiction to the traditional LDL-C hypothesis of decreasing mortality
Faculty Chairman – Neal Rouzier, MD
11:30 – 12:30 PM
If you have never heard of, or do not understand the Notch pathway, then you will not understand the importance of estradiol in protecting against DM, CVD, inflammation, and cancer.
Faculty Chairman – Neal Rouzier, MD
12:30 – 1:30 PM – LUNCH
1:30 – 3:30 PM
Transgender and Non-Binary Clinical Care – Culture, Terminology, Health Disparities, and Hormone Therapy Management
Guest Faculty: Madeline Deutsch, MD
3:30 – 4:00 PM – BREAK
4:00 – 5:00 PM
Suicide in Clinical Practice & the Impact of Two Pandemics…..It’s not a matter of if, rather when
- Clinical utility of appropriate screening tools
- Protective factors-Increasing knowledge and capabilities
- Fostering confidence strategies to working in an area that can be dauting.
Guest Faculty: Deb York, MSN, PMHNP-BC, CCRA
ADJOURN
7:30 AM
Live Stream Opens
7:30 – 8:00 AM – (Central Time)
Registration Opens
8:00 – 9:00 AM
Paradigms of Cancer – Explore our current understanding of cancer as an evolutional disease as opposed to a primarily genetic one
Guest Faculty – Jason Fung, MD
9:00 – 10:00 AM
Insulin Resistance – What Is It and Why It Matters
Guest Faculty – Benjamin Bikman, Ph.D.
10:00 – 10:30 AM – BREAK
10:30 – 11:30 AM
Using Evolution in Today’s Cancer Clinic
Guest Faculty – Dawn Lemanne, MD, MPH
This lecture looks at cancer as part of an ecosystem. That is, one human patient is an ecosystem invaded by a cancer. One can then think of a cancer as a detrimental species that learns to thrive at the expense of the rest of the “ecosystem,” the unfortunate host is a human being. In any patient, a cancer always evolves during treatment to become resistant to that treatment. Taking instruction from other ecological problems, such as extinction of species, or sustainable pest control in agriculture, oncologists are now exploring fasting and other inexpensive, easily available maneuvers, such as hyperbaric oxygen treatment and faster drug cycling to drive a patient’s cancer to extinction, or to enable a patient to live with it.
11:30 – 12:30
Nutrition and Cancer
Jason Fung, MD
12:30 – 1:30 pm – LUNCH
1:30 – 2:30 PM
Where It Comes From: The Origins of Insulin Resistance
Guest Faculty – Benjamin Bikman Ph.D.
2:30 – 3:00 PM
Break
3:00 – 4:00 PM
Type 2 Diabetes, Etiology and Reversibility
Guest Faculty – Jason Fung, MD
4:00 – 5:00 PM
Using Fasting and Carbohydrate Restriction in the Cancer Clinic
Cases and peer-reviewed data on
- Keto diet as powerful adjunct to radiation therapy
- Ketosis as adjunct in cancer cachexia
- 48-hour or longer fasts during chemo, to prevent chemotherapy-induced side effects
- Moderate carbohydrate restriction for colorectal cancer and estrogen-sensitive breast cancers
- Fasting as sole treatment for some cancer patients
- Who should not fast
- Cancers that may worsen with fasting
Guest Faculty – Dawn Lemanne, MD, MPH
5:00 – 6:00 PM
A Very Special In-Person Inverview with Glenn Sabin (Author of N of 1) and Dawn Lemanne, MD
“Twenty-five years ago my doctors ad no cure for my cancer, so I went on a quest to find my own treatment. This is my story.”
ADJOURN
7:30 AM
Live Stream Opens
7:30 – 8:00 AM – (Central Time)
Registration Opens
8:00 – 9:00 AM
Breast Cancer is the Leading Cause of Cancer in Women
- Do the benefits of endocrine therapy outweigh the risks?
- How do we prevent the toxicity of breast cancer endocrine therapy?
- Over 50% of breast cancer patients on endocrine therapy resistance resulting in breast cancer recurrence over time. What is the potential mechanism for failure? Are we increasing the risk?
Faculty Chairman – Neal Rouzier, MD
9:00 – 10:00 AM
Even though Obesity and Diabetes Increase CVD and all-cause mortality, there is less awareness that weight gain, obesity, and DM increase the risk of Cancer also. What else can we offer patients?
- Increased body mass (BMI) is linked to increased death from every cause including CVD and cancer
- Statins and Metformin decrease testosterone, what are the metabolic effects of testosterone suppression
- Are there studies to demonstrate an increased risk of cancer in men with low testosterone levels?
- Are there studies that demonstrate testosterone therapy reduces BMI, visceral fat, IR and DM?
Faculty Chairman – Neal Rouzier, MD
10:00 – 10:30 AM – BREAK
10:30 – 11:30 AM
Testosterone and Risk/Benefit with Prostate Cancer is always a Controversial Topic
- Low levels of testosterone increase incidence and severity of prostate cancer and high levels are protective.
- Testosterone is safe and efficacious in prostate cancer survivors
- Estradiol is as much a male hormone as it is a female hormone
Faculty Chairman – Neal Rouzier, MD
11:30 – 12:30 PM
An Overview of the Most Recent Treatments/Therapies for Breast Cancer, Endometrial Cancer, and Ovarian Cancer
Faculty Chairman – Neal Rouzier, MD
ADJOURN
ACCREDITATION STATEMENTS
AMA PRA Category 1 Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Worldlink Medical. The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 19 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in this activity.
The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Nursing Statement
Foundation for Care Management is accredited as a provider of nursing continuing professional development
by the American Nurses Credentialing Center’s Commission on Accreditation.
Pharmacy Statement
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-9999-21-010-L01-P Objectives appropriate for pharmacists. This activity is 19 Contact Hours Pharmacy Credit. *This CME is Knowledge Based (K). Initial release October 1, 2021.
Speakers
Jason Fung, MD
Featured Speaker
Madeline Deutsch MD, MPH
Associate Professor of Clinical Family & Community Medicine at UCSF
Neal Rouzier, MD
Faculty Chairman
Dawn Lemanne, MD, MPH
Clinical Assistant Professor of Medicine, University of Arizona
Deb York, MSN, PMHNP-BC, APRN, CCRA
Director of Clinical Research & Development
Benjamin Bikman, Ph.D
Associate Professor Department of Cell Biology and Physiology, BYU
Location & Travel Details
HYATT REGENCY LOST PINES RESORT AND SPA
Nestled on 405 acres along the Lower Colorado River, our Austin Hill Country resort provides a relaxing getaway, just 20 minutes from Austin-Bergstrom International Airport. Tee off from our award-winning 18-hole golf course, book your adventure with Renegade Trailhead and explore the grounds on horseback, or relax by our temperature controlled pool – there’s something for everyone here.
Travel Details
Airport
Austin-Bergstrom International Airport (AUS)
Accommodations
Room Block Rate is $199.00
The Room block has expired please book direct through hotel or other discount site. If you need assistance with a room contact us at [email protected]